GBP8.45
2.30% yesterday
London, May 16, 05:35 pm CET
ISIN
GB00BN4HT335
Symbol
INDV
Sector
Industry

Indivior Stock price

GBP8.45
+1.63 23.83% 1M
+0.76 9.82% 6M
-1.80 17.53% YTD
-5.08 37.54% 1Y
-6.41 43.13% 3Y
+5.94 236.45% 5Y
-2.56 23.29% 10Y
London, Closing price Fri, May 16 2025
+0.19 2.30%
ISIN
GB00BN4HT335
Symbol
INDV
Sector
Industry

Key metrics

Market capitalization GBP1.05b
Enterprise Value GBP1.05b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 9.92
EV/Sales (TTM) EV/Sales 1.15
P/S ratio (TTM) P/S ratio 1.15
P/B ratio (TTM) P/B ratio negative
Revenue growth (TTM) Revenue growth 2.47%
Revenue (TTM) Revenue GBP916.88m
EBIT (operating result TTM) EBIT GBP219.71m
Free Cash Flow (TTM) Free Cash Flow GBP106.02m
Cash position GBP288.98m
EPS (TTM) EPS GBP-0.18
P/E forward 8.66
P/S forward 1.36
EV/Sales forward 1.36
Short interest 310.00%
Show more

Is Indivior a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,790 stocks worldwide.

Indivior Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a Indivior forecast:

7x Buy
100%

Analyst Opinions

7 Analysts have issued a Indivior forecast:

Buy
100%

Financial data from Indivior

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
917 917
2% 2%
100%
- Direct Costs 185 185
10% 10%
20%
759 759
5% 5%
83%
- Selling and Administrative Expenses 432 432
28% 28%
47%
- Research and Development Expense 80 80
7% 7%
9%
239 239
558% 558%
26%
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT 220 220
1,776% 1,776%
24%
Net Profit -29 -29
668% 668%
-3%

In millions GBP.

Don't miss a Thing! We will send you all news about Indivior directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Indivior PLC is a holding company, which engages in the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence. Its products include Suboxone Film, Suboxone Tablet, and Subutex Tablet. It operates through the following geographical segments: United States, Rest of World, and United Kingdom. The company was founded on September 26, 2014 and is headquartered in Slough, the United Kingdom.

Head office United Kingdom
CEO Joseph Ciaffoni
Employees 1,051
Founded 2014
Website indivior.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today